165 related articles for article (PubMed ID: 17064682)
1. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.
Joshi I; Taylor CP
Eur J Pharmacol; 2006 Dec; 553(1-3):82-8. PubMed ID: 17064682
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice.
Bian F; Li Z; Offord J; Davis MD; McCormick J; Taylor CP; Walker LC
Brain Res; 2006 Feb; 1075(1):68-80. PubMed ID: 16460711
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
Taylor CP; Angelotti T; Fauman E
Epilepsy Res; 2007 Feb; 73(2):137-50. PubMed ID: 17126531
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic-like activity of pregabalin in the Vogel conflict test in α2δ-1 (R217A) and α2δ-2 (R279A) mouse mutants.
Lotarski SM; Donevan S; El-Kattan A; Osgood S; Poe J; Taylor CP; Offord J
J Pharmacol Exp Ther; 2011 Aug; 338(2):615-21. PubMed ID: 21558437
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant activity of pregabalin in the maximal electroshock-induced seizure assay in α2δ1 (R217A) and α2δ2 (R279A) mouse mutants.
Lotarski S; Hain H; Peterson J; Galvin S; Strenkowski B; Donevan S; Offord J
Epilepsy Res; 2014 Jul; 108(5):833-42. PubMed ID: 24698052
[TBL] [Abstract][Full Text] [Related]
6. Redundancy of Cav2.1 channel accessory subunits in transmitter release at the mouse neuromuscular junction.
Kaja S; Todorov B; van de Ven RC; Ferrari MD; Frants RR; van den Maagdenberg AM; Plomp JJ
Brain Res; 2007 Apr; 1143():92-101. PubMed ID: 17320843
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic inhibitory actions of pregabalin on excitatory transmission in superficial dorsal horn of mouse spinal cord: further characterization of presynaptic mechanisms.
Matsuzawa R; Fujiwara T; Nemoto K; Fukushima T; Yamaguchi S; Akagawa K; Hori Y
Neurosci Lett; 2014 Jan; 558():186-91. PubMed ID: 24269977
[TBL] [Abstract][Full Text] [Related]
8. Acute modulation of calcium currents and synaptic transmission by gabapentinoids.
Uchitel OD; Di Guilmi MN; Urbano FJ; Gonzalez-Inchauspe C
Channels (Austin); 2010; 4(6):490-6. PubMed ID: 21150315
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
Micheva KD; Taylor CP; Smith SJ
Mol Pharmacol; 2006 Aug; 70(2):467-76. PubMed ID: 16641316
[TBL] [Abstract][Full Text] [Related]
10. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
Horga de la Parte JF; Horga A
Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of pregabalin in partial epilepsy.
Beydoun A; Nasreddine W; Atweh S
Expert Rev Neurother; 2008 Jul; 8(7):1013-24. PubMed ID: 18590472
[TBL] [Abstract][Full Text] [Related]
12. Vecuronium suppresses transmission at the rat phrenic neuromuscular junction by inhibiting presynaptic L-type calcium channels.
Ji F; Han J; Liu B; Wang H; Shen G; Tao J
Neurosci Lett; 2013 Jan; 533():1-6. PubMed ID: 23200725
[TBL] [Abstract][Full Text] [Related]
13. Pregabalin pharmacology and its relevance to clinical practice.
Ben-Menachem E
Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511
[TBL] [Abstract][Full Text] [Related]
14. Reduced ACh release at neuromuscular synapses of heterozygous leaner Ca(v)2.1-mutant mice.
Kaja S; Van De Ven RC; Frants RR; Ferrari MD; Van Den Maagdenberg AM; Plomp JJ
Synapse; 2008 May; 62(5):337-44. PubMed ID: 18293354
[TBL] [Abstract][Full Text] [Related]
15. Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits.
Li Z; Taylor CP; Weber M; Piechan J; Prior F; Bian F; Cui M; Hoffman D; Donevan S
Eur J Pharmacol; 2011 Sep; 667(1-3):80-90. PubMed ID: 21651903
[TBL] [Abstract][Full Text] [Related]
16. The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?
Stahl SM; Porreca F; Taylor CP; Cheung R; Thorpe AJ; Clair A
Trends Pharmacol Sci; 2013 Jun; 34(6):332-9. PubMed ID: 23642658
[TBL] [Abstract][Full Text] [Related]
17. The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo.
Bauer CS; Rahman W; Tran-van-Minh A; Lujan R; Dickenson AH; Dolphin AC
Biochem Soc Trans; 2010 Apr; 38(2):525-8. PubMed ID: 20298215
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of recombinant N-type and native high voltage-gated neuronal Ca2+ channels by AdGABA: mechanism of action studies.
Martínez-Hernández E; Sandoval A; González-Ramírez R; Zoidis G; Felix R
Toxicol Appl Pharmacol; 2011 Feb; 250(3):270-7. PubMed ID: 21059371
[TBL] [Abstract][Full Text] [Related]
19. The alpha2-delta protein: an auxiliary subunit of voltage-dependent calcium channels as a recognized drug target.
Thorpe AJ; Offord J
Curr Opin Investig Drugs; 2010 Jul; 11(7):761-70. PubMed ID: 20571971
[TBL] [Abstract][Full Text] [Related]
20. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
